Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

[Veno-lymphatic insufficiency. 4,729 patients undergoing hormonal and procyanidol oligomer therapy].

Henriet JP.

Phlebologie. 1993 Apr-Jun;46(2):313-25. French. No abstract available.

PMID:
8362014
2.

[Chorioretinal circulation and dazzling: use of procyanidol oligomers (Endotelon)].

Boissin JP, Corbe C, Siou A.

Bull Soc Ophtalmol Fr. 1988 Feb;88(2):173-4, 177-9. French. No abstract available.

PMID:
3063403
4.

[Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent].

Cervantes A, Gorodovsky J, Peña A, Campos J.

Ginecol Obstet Mex. 1976 Aug;40(238):113-6. Spanish. No abstract available.

PMID:
786800
5.

[Clinical and capillaroscopic evaluation of chronic uncomplicated venous insufficiency with procyanidins extracted from vitis vinifera].

Costantini A, De Bernardi T, Gotti A.

Minerva Cardioangiol. 1999 Jan-Feb;47(1-2):39-46. Italian.

PMID:
10356940
6.

[A low dosage pile, until menopause, will facilitate medical practice.. Interview by Robert Henry].

Rioux JE.

Union Med Can. 1993 Jul-Aug;122(4):242-6. French. No abstract available.

PMID:
8367910
7.

[Treatment possibilities of early stages of venous insufficiency caused by oral contraceptives].

Kalinski S, Neumann D.

Med Welt. 1979 Aug 10;30(31-32):1169-72. German. No abstract available.

PMID:
470593
8.

[Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors].

Lauritzen C.

Zentralbl Gynakol. 1990;112(17):1071-90. Review. German.

PMID:
2264417
9.

[Female hormones and oral health].

Meijer van Putten JB.

Ned Tijdschr Tandheelkd. 1998 Nov;105(11):416-8. Dutch.

PMID:
11928463
10.
11.

[Heavy legs, venous insufficiency of the legs and hormone substitution therapy].

Haesler E, Hayoz D.

Praxis (Bern 1994). 2000 Jun 29;89(25-26):1098-104. Review. French.

PMID:
11367592
12.

The action of ovarian hormones in cardiovascular disease.

Medina RA, Aranda E, Verdugo C, Kato S, Owen GI.

Biol Res. 2003;36(3-4):325-41. Review.

PMID:
14631866
13.

[Dermatoses caused by estrogens and progesterone: an upcoming nosology].

Estève E.

Ann Dermatol Venereol. 1998 Aug;125(8):484-5. French. No abstract available.

PMID:
9747310
14.

[Protective effect of procyanidolic oligomers on experimental lathyrism in rats].

Gendre PM, Laparra J, Barraud E.

Ann Pharm Fr. 1985;43(1):61-71. French. No abstract available.

PMID:
4062183
15.

[A study of the effects of procyanidol oligomers on capillary resistance in hypertension and in certain nephropathies (author's transl)].

Lagrue G, Olivier-Martin F, Grillot A.

Sem Hop. 1981 Sep 18-25;57(33-36):1399-401. French.

PMID:
6270799
16.

[Hyaluronic acid (hyaluronan) levels in pathological human saphenous veins. Effects of procyanidol oligomers].

Drubaix I, Maraval M, Robert L, Robert AM.

Pathol Biol (Paris). 1997 Jan;45(1):86-91. French.

PMID:
9097853
17.
18.

Exogenous sex hormones and thrombophilia.

Walker ID.

Obstet Gynecol Clin North Am. 2006 Sep;33(3):467-79, x. Review.

PMID:
16962922
19.

Hormone replacement therapy and hypertension.

Felmeden DC, Lip GY.

Blood Press. 2000;9(5):246-9. Review.

PMID:
11193126
20.

[Hormone therapy and cardiovascular risk].

Wütschert R, Cirafici P.

Praxis (Bern 1994). 2000 Jun 29;89(25-26):1090-7. Review. French.

PMID:
11367591

Supplemental Content

Support Center